Article Versions Notes

Emdina A, Hermann P, Varges D, Nuhn S, Goebel S, Bunck T, Maass F, Schmitz M, Llorens F, Kruse N, et al. Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline. Diagnostics. 2022; 12(5):1259. https://doi.org/10.3390/diagnostics12051259

Emdina, Anna, Peter Hermann, Daniela Varges, Sabine Nuhn, Stefan Goebel, Timothy Bunck, Fabian Maass, Matthias Schmitz, Franc Llorens, Niels Kruse, and et al. 2022. "Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline" Diagnostics 12, no. 5: 1259. https://doi.org/10.3390/diagnostics12051259

Emdina, A., Hermann, P., Varges, D., Nuhn, S., Goebel, S., Bunck, T., Maass, F., Schmitz, M., Llorens, F., Kruse, N., Lingor, P., Mollenhauer, B., & Zerr, I. (2022). Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline. Diagnostics, 12(5), 1259. https://doi.org/10.3390/diagnostics12051259